Type 2 Diabetes Drug Shows Potential to Lower Dementia Risk by 35%
Large Korean study suggests SGLT-2 inhibitors could reduce dementia risk, but further trials are needed to confirm findings.
- Study analyzed data from over 110,000 type 2 diabetics aged 40-69.
- SGLT-2 inhibitors linked to lower risk of Alzheimer's and vascular dementia.
- Experts call for robust clinical trials to validate results.
- Repurposing existing drugs could accelerate and reduce costs of dementia treatment.
- Researchers emphasize the need to understand the mechanisms behind the observed effects.
The Telegraph 
The Guardian 
The Independent 
Evening Standard 